Advertisement

Topics

Latest "Management acute infection direct acting antiviral therapy" News Stories

23:22 EST 16th February 2019 | BioPortfolio

Here are the most relevant search results for "Management acute infection direct acting antiviral therapy" found in our extensive news archives from over 250 global news sources.

More Information about Management acute infection direct acting antiviral therapy on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Management acute infection direct acting antiviral therapy for you to read. Along with our medical data and news we also list Management acute infection direct acting antiviral therapy Clinical Trials, which are updated daily. BioPortfolio also has a large database of Management acute infection direct acting antiviral therapy Companies for you to search.

Showing "Management acute infection direct acting antiviral therapy" News Articles 1–25 of 22,000+

Saturday 16th February 2019

Week in Review: CStone's Hong Kong IPO to Raise $304 Million at $1.5 Billion Valuation Next Week

Deals and Financings • CStone Pharma of Suzhou will raise $304 million next week in its Hong Kong IPO at a valuation of $1.5 billion to advance fourteen clinical-stage oncology candidates;• Shanghai HaiHe Biopharma, an oncology company with ten molecules in clinical trials, announced a $146.6 million funding;• Burning Rock Biotech, a Guangzhou diagnostics company, closed a $126 mill...


How a gene therapy pioneer, once referred to as a 'refugee' has found a renewed calling in the field. https://buff.ly/2EgKMSD 

How a gene therapy pioneer, once referred to as a 'refugee' has found a renewed calling in the field. https://buff.ly/2EgKMSD 

Killer Snails Give Scientists Clues to Develop Better, Faster-Acting Insulin (with video): http://ow.ly/cfka30nGHXM pic.twitter.com/IWSDJsW2eg

Killer Snails Give Scientists Clues to Develop Better, Faster-Acting Insulin (with video): http://ow.ly/cfka30nGHXM  pic.twitter.com/IWSDJsW2eg


Merck, Pfizer drug combo extends kidney cancer survival: study

A combination of Merck & Co's immunotherapy Keytruda and Pfizer Inc's Inlyta helped patients with advanced kidney cancer live longer than those receiving and older Pfizer standalone therapy, according to data from a late-stage study presented on Satu...

KEYTRUDA® (pembrolizumab) in Combination with Inlyta® (axitinib) Reduced Risk of Death by Nearly Half Compared to Sunitinib as First-Line Treatment for Advanced Renal Cell Carcinoma (RCC)

Results from Phase 3 KEYNOTE-426 Study Presented Today at the 2019 Genitourinary Cancers Symposium (ASCO GU) and Published in the New England Journal of Medicine Also Showed Risk of Progression or Death Reduced by 31 Percent Data Consistent Across all IMDC Risk Groups and Regardless of PD-L1 Expression Merck (NYSE: MRK), known as MSD ou...

AVEO Oncology Announces Oral Presentation of TIVO-3 Trial Topline Results at the 2019 ASCO Genitourinary Cancers Symposium

AVEO Oncology (NASDAQ:AVEO) today announced the presentation of data from the Phase 3 TIVO-3 study of tivozanib (FOTIVDA®) versus sorafenib in refractory advanced or metastatic renal cell carcinoma (RCC). The data were presented by Brian Rini, MD, Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, and Di...

ControlRad Adds Industry-Veteran Chris Fair to its Executive Management Team

PHILADELPHIA (PRWEB) February 15, 2019 ControlRad, LLC , a privately-held medical technology company, focused on dramatically reducing the amount of radiation exposure during fluoroscopically guided procedures, is pleased to announce that Chris Fair has joined its senior management team as...

$AMGN Granted FDA ODD for the treatment of Acute Myeloid Leukemia https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=675018 …

$AMGN Granted FDA ODD for the treatment of Acute Myeloid Leukemia https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=675018 …

News digest – HPV stigma, ultra-processed foods, ‘simple’ cancer blood test and why measles isn’t a cancer cure

Science blog Stigma around HPV infection causes concern Misunderstanding and perceived stigma around the human papillomavirus (HPV) infection is concerningly high and could put women off cervical screening, reports the Independent and others. The results

Friday 15th February 2019

Company Profile for Novus Therapeutics, Inc.

Novus Therapeutics, Inc. (“Novus”) is a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (“ENT”). Novus has two technologies, each that has the potential to be developed for multiple ENT indications. Novus’ lead product candidate (OP0201) is a surfactant-based, drug-device co...

MKSAP: 60-year-old woman with H. pylori gastritis

Test your medicine knowledge with the MKSAP challenge, in partnership with the American College of Physicians. A 60-year-old woman is evaluated 1 month after completing a 14-day course of Helicobacter pylori eradication therapy consisting of amoxicillin, clarithromycin, and omeprazole. Initial upper endoscopy before treatment showed patchy gastric erythema with no ulcers or erosions, and biops...

Eradication of H. Pylori should be confirmed using the urea breath test or fecal antigen test

Test your medicine knowledge with the MKSAP challenge, in partnership with the American College of Physicians. A 60-year-old woman is evaluated 1 month after completing a 14-day course of Helicobacter pylori eradication therapy consisting of amoxicillin, clarithromycin, and omeprazole. Initial upper endoscopy before treatment showed patchy gastric erythema with no ulcers or erosions, and biops...

ASCO GU 2019: Updates on treatment and management of bladder cancer

Professor Matthew Galsky chairs a discussion with Professor Ananya Choudhury, Professor Joaquim Bellmunt and Dr Andrea Necchi on the latest data presented at ASCO GU 2019 in San Francisco, specifically focused on the treatment and management of urothelial...

ASCO GU 2019: Treatment and management of hormone-sensitive metastatic prostate cancer

Professor Karim Fizazi and Professor Eleni Efstathiou set the scene in current care and discuss the treatment options available for hormone-sensitive metastatic prostate cancer, highlighting the unmet need in recurrent metastatic disease. New updates to...

STREAM trial: Enzalutamide and androgen deprivation therapy with salvage radiation in men with high-risk PSA recurrent PC

Prof Andrew Armstrong speaks to ecancer at the 2019 ASCO Genitourinary Cancers Symposium about the STREAM trial investigating the use of enzalutamide and androgen deprivation therapy (ADT) with salvage radiation in patients with high-risk PSA recurrent...

Analysis of acute toxicity from PACE-B: Comparing SBRT to CFMHRT for localised prostate cancer

Dr Nicholas van As speaks to ecancer at the 2019 ASCO Genitourinary Cancers Symposium about analysis of acute toxicity from the randomised phase III PACE-B trial comparing tereotactic body radiotherapy (SBRT) to conventionally fractionated or moderately...

Aradigm Announces Plans for Reorganization Under Chapter 11 of the U.S. Bankruptcy Code

Aradigm Corporation (OTCQB: ARDM) (“Aradigm” or the “Company”) has filed for protection under Chapter 11 of the U.S. Bankruptcy Code in the Alameda County Court District to facilitate the sale of its assets. On February 11, 2019, Aradigm determined that without confirmation of funding from their primary investor and partner, the Company would not...

Antibe Therapeutics Reports Q3 2019 Interim Financial and Operating Results

Antibe Therapeutics Inc. ("Antibe" or the “Company”) (TSXV: ATE, OTCQB: ATBPF) filed its financial and operating results on Friday, February 15th for the fiscal quarter ended December 31, 2018. The Company’s unaudited fiscal Q3 2019 condensed interim consolidated financial statements and MD&A are available on SEDAR. About Antib...

[Correspondence] Intracerebral haemorrhage during alemtuzumab administration

Alemtuzumab is a monoclonal antibody that targets CD52, a protein expressed at high levels on T and B lymphocytes, and at lower levels on other components of the innate immune system.1 Alemtuzumab 12 mg per day is administered intravenously over five consecutive days, followed by a second course on three consecutive days 12 months later.1 Alemtuzumab is a potent disease-modifying therapy for the t...

AHF Lauds Congress and the President for Boosting Global AIDS Funding

Funding bill will appropriate $5.72 billion for PEPFAR and $1.35 billion for the Global Fund to Fight AIDS, Tuberculosis and Malaria AIDS Healthcare Foundation (AHF) praised today the U.S. Congress and President Trump for adopting bipartisan appropriations l

Avapritinib receives Phase III clinical trial approval for GIST in China

SUZHOU, China, Feb. 15, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone") today announced that the National Medical Products Administration (NMPA) recently approved a Phase III clinical trial in China for its partnered drug candidate avapritinib as a third-line treatment against KIT-driven gastrointestinal stromal tumors (GIST). The study will be part of the global VOYAGER Phase II...

New Therapy for Aggressive Blood Cancer Discovered

NewsAcute myeloid leukemia is the most common form of acute leukemia.Contributed Author: 

Dr. Martin Courtney Offers LANAP Laser Gum Disease Treatment in the San Fernando Valley

The LANAP treatment provides a solution for patients looking to address their gum disease without the fear of cut and sew surgery. NORTHRIDGE, Calif. (PRWEB) February 15, 2019 Dr. Martin Courtney is pleased to offer the LANAP® protocol gum disease treatment and LAPIP™ protocol for ailing dental implants to the Northridge and surrounding areas. Dr. Courtney's decision to become LANAP pr...

MRI is good first-line option in children with suspected acute appendicitis

Perio-Implant Care Emphasizes the Importance of Gum Disease Awareness and Treatment in Northern Kentucky

Dr. Ryan Estes and Dr. Allison Marlow explain how untreated gum disease can lead to dangerous problems both in and outside of the mouth. FLORENCE, Ky. (PRWEB) February 15, 2019 In observance of Gum Disease Awareness Month, Dr. Ryan Estes and Dr. Allison Marlow of Perio-Implant Care are urging patients to take their oral health seriously. With recent suggested links between gum disease and heart d...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks